Evidence map›Paper›PMID 26863025›Full record

ArticlePLoS genetics2016

A Screen for Modifiers of Cilia Phenotypes Reveals Novel MKS Alleles and Uncovers a Specific Genetic Interaction between osm-3 and nphp-4.

Svetlana V Masyukova, Dawn E Landis, Scott J Henke, Corey L Williams, Jay N Pieczynski, Kelly N Roszczynialski, Jannese E Covington, Erik B Malarkey, Bradley K Yoder

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Disease Modeling To Understand the Pathomechanisms of Human Genetic Kidney Disorders.Clinical journal of the American Society of Nephrology : CJASN · 2020
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Svetlana V MasyukovaDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham Medical School, Birmingham, Alabama, United States of America.
Dawn E LandisDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham Medical School, Birmingham, Alabama, United States of America.
Scott J HenkeDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham Medical School, Birmingham, Alabama, United States of America.
Corey L WilliamsDepartment of Pharmacology and Therapeutics, College of Medicine, University of Florida, Gainesville, Florida, United States of America.
Jay N PieczynskiDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham Medical School, Birmingham, Alabama, United States of America.
Kelly N RoszczynialskiDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham Medical School, Birmingham, Alabama, United States of America.
Jannese E CovingtonDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham Medical School, Birmingham, Alabama, United States of America.
Erik B MalarkeyDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham Medical School, Birmingham, Alabama, United States of America.
Bradley K YoderDepartment of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham Medical School, Birmingham, Alabama, United States of America.
University of Alabama at Birmingham · USUniversity of Florida · US

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MICHAEL JAMES BERTRAM · 1985 to 2026
$165.9M
UAB Recessive PKD Research and Translational Core CenterP30DK074038 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GUAY-WOODFORD, LISA MARIE · 2005 to 2019
$16.6M
Cilia and Cystic Kidney DiseaseR01DK065655 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI YODER, BRADLEY K. · 2004 to 2017
$4.4M
NCI NIH HHS P30 CA013148NIDDK NIH HHS 2P30DK074038NIDDK NIH HHS 5R01DK065655NIDDK NIH HHS P30 DK074038NIDDK NIH HHS R01 DK065655
6 · The paper itself

Abstract

Nephronophthisis (NPHP) is a ciliopathy in which genetic modifiers may underlie the variable penetrance of clinical features. To identify modifiers, a screen was conducted on C. elegans nphp-4(tm925) mutants. Mutations in ten loci exacerbating nphp-4(tm925) ciliary defects were obtained. Four loci have been identified, three of which are established ciliopathy genes mks-1, mks-2, and mks-5. The fourth allele (yhw66) is a missense mutation (S316F) in OSM-3, a kinesin required for cilia distal segment assembly. While osm-3(yhw66) mutants alone have no overt cilia phenotype, nphp-4(tm925);osm-3(yhw66) double mutants lack distal segments and are dye-filling (Dyf) and osmotic avoidance (Osm) defective, similar to osm-3(mn357) null mutants. In osm-3(yhw66) mutants anterograde intraflagellar transport (IFT) velocity is reduced. Furthermore, expression of OSM-3(S316F)::GFP reduced IFT velocities in nphp-4(tm925) mutants, but not in wild type animals. In silico analysis indicates the S316F mutation may affect a phosphorylation site. Putative phospho-null OSM-3(S316F) and phospho-mimetic OSM-3(S316D) proteins accumulate at the cilia base and tip respectively. FRAP analysis indicates that the cilia entry rate of OSM-3(S316F) is slower than OSM-3 and that in the presence of OSM-3(S316F), OSM-3 and OSM-3(S316D) rates decrease. In the presence OSM-3::GFP or OSM-3(S316D)::GFP, OSM-3(S316F)::tdTomato redistributes along the cilium and accumulates in the cilia tip. OSM-3(S316F) and OSM-3(S316D) are functional as they restore cilia distal segment formation in osm-3(mn357) null mutants; however, only OSM-3(S316F) rescues the osm-3(mn357) null Dyf phenotype. Despite rescue of cilia length in osm-3(mn357) null mutants, neither OSM-3(S316F) nor OSM-3(S316D) restores ciliary defects in nphp-4(tm925);osm-3(yhw66) double mutants. Thus, these OSM-3 mutations cause NPHP-4 dependent and independent phenotypes. These data indicate that in addition to regulating cilia protein entry or exit, NPHP-4 influences localization and function of a distal ciliary kinesin. Moreover, data suggest human OSM-3 homolog (Kif17) could act as a modifying locus affecting disease penetrance or expressivity in NPHP patients.

Indexed as

AllelesEpistasis, GeneticGenetic TestingAnimalsCaenorhabditis elegansCaenorhabditis elegans ProteinsCiliaCiliary Motility DisordersEncephaloceleGenetic Complementation TestKinesinsMutagenesisMutationPhenotypePhosphorylationPolycystic Kidney DiseasesCaenorhabditis elegans ProteinsKinesinsnephrocystin 4, C elegansOSM-3 protein, C elegans

Identifiers

PMID26863025
PMCPMC4749664
OpenAlexW2254931448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.